Establishment Labs (NASDAQ:ESTA) Hits New 1-Year High – Here’s Why

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $78.25 and last traded at $75.3890, with a volume of 77915 shares trading hands. The stock had previously closed at $76.00.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ESTA. Citigroup boosted their price objective on Establishment Labs from $62.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Needham & Company LLC reiterated a “buy” rating and issued a $84.00 price objective on shares of Establishment Labs in a report on Monday, January 12th. Canaccord Genuity Group upped their target price on shares of Establishment Labs from $72.00 to $85.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. JPMorgan Chase & Co. increased their price objective on shares of Establishment Labs from $71.00 to $80.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Establishment Labs in a report on Monday, December 29th. Six research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $78.86.

Establishment Labs Stock Down 1.2%

The company has a 50-day moving average of $70.82 and a 200-day moving average of $57.14. The company has a current ratio of 3.33, a quick ratio of 2.10 and a debt-to-equity ratio of 15.06. The company has a market capitalization of $2.18 billion, a price-to-earnings ratio of -26.51 and a beta of 0.99.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ESTA. Quarry LP acquired a new stake in shares of Establishment Labs during the third quarter worth about $34,000. Kestra Advisory Services LLC purchased a new position in Establishment Labs during the fourth quarter worth approximately $47,000. State of Wyoming purchased a new position in shares of Establishment Labs during the 3rd quarter worth $71,000. Osaic Holdings Inc. boosted its holdings in Establishment Labs by 900.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock valued at $85,000 after purchasing an additional 1,800 shares during the last quarter. Finally, CWM LLC lifted its holdings in Establishment Labs by 45.9% in the second quarter. CWM LLC now owns 2,182 shares of the company’s stock valued at $93,000 after acquiring an additional 686 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.